When a “Head Start” Becomes Trade Secret Misappropriation: Protecting Pharmaceutical Innovation During Business Discussions
Pharmaceutical innovation often begins long before there is a commercial product. An academic investigator, physician, entrepreneur, or small biotechnology company may identify a promising compound, formulation, drug-delivery system, manufacturing process, or new therapeutic use. But turning that concept into an FDA-approved product requires money, development expertise, manufacturing capabilities, and often a commercial partner. That creates […]